Correlation Between SK Bioscience and OLIPASS
Can any of the company-specific risk be diversified away by investing in both SK Bioscience and OLIPASS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SK Bioscience and OLIPASS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SK Bioscience Co and OLIPASS, you can compare the effects of market volatilities on SK Bioscience and OLIPASS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SK Bioscience with a short position of OLIPASS. Check out your portfolio center. Please also check ongoing floating volatility patterns of SK Bioscience and OLIPASS.
Diversification Opportunities for SK Bioscience and OLIPASS
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 302440 and OLIPASS is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding SK Bioscience Co and OLIPASS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OLIPASS and SK Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SK Bioscience Co are associated (or correlated) with OLIPASS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OLIPASS has no effect on the direction of SK Bioscience i.e., SK Bioscience and OLIPASS go up and down completely randomly.
Pair Corralation between SK Bioscience and OLIPASS
Assuming the 90 days trading horizon SK Bioscience Co is expected to generate 0.4 times more return on investment than OLIPASS. However, SK Bioscience Co is 2.48 times less risky than OLIPASS. It trades about -0.02 of its potential returns per unit of risk. OLIPASS is currently generating about -0.03 per unit of risk. If you would invest 5,210,000 in SK Bioscience Co on September 5, 2024 and sell it today you would lose (235,000) from holding SK Bioscience Co or give up 4.51% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 72.88% |
Values | Daily Returns |
SK Bioscience Co vs. OLIPASS
Performance |
Timeline |
SK Bioscience |
OLIPASS |
SK Bioscience and OLIPASS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SK Bioscience and OLIPASS
The main advantage of trading using opposite SK Bioscience and OLIPASS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SK Bioscience position performs unexpectedly, OLIPASS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OLIPASS will offset losses from the drop in OLIPASS's long position.SK Bioscience vs. Woori Technology | SK Bioscience vs. NICE Information Service | SK Bioscience vs. Dongil Technology | SK Bioscience vs. Solution Advanced Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |